Troy Edward Wilson, President and CEO at Kura Oncology, Inc. (KURA), sold 182,104 shares at $20.23 ($3.7M) on 2024-01-24, disclosed to the SEC on 2024-01-26.
Open-market sale of $3.7M KURA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.23 | 6,945 | $140K | 3.8% |
| 2 | $20.23 | 6,945 | $140K | 3.8% |
| 3 | $20.23 | 84,107 | $1.7M | 46.2% |
| 4 | $20.23 | 84,107 | $1.7M | 46.2% |
| Total | $20.23 avg | 182,104 | $3.7M | 100% |
| Filing → |
| KURA | BUY | 2026-08-17 | $1.1M | — | Filing → |
| PBYI | SELL | 2026-06-15 | $78K | — | Filing → |
| KURA | SELL | 2025-09-29 | $655K | — | Filing → |